Drug Shortage Report for SANDOZ POSACONAZOLE
Report ID | 218024 |
Drug Identification Number | 02496259 |
Brand name | SANDOZ POSACONAZOLE |
Common or Proper name | POSACONAZOLE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | POSACONAZOLE |
Strength(s) | 100MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL |
Packaging size | 60GRT |
ATC code | J02AC |
ATC description | ANTIMYCOTICS FOR SYSTEMIC USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-01-31 |
Estimated end date | 2024-04-19 |
Actual end date | 2024-04-23 |
Shortage status | Resolved |
Updated date | 2024-04-24 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-04-24 | English | Compare |
v5 | 2024-04-23 | French | Compare |
v4 | 2024-04-23 | English | Compare |
v3 | 2024-02-01 | English | Compare |
v2 | 2024-01-31 | French | Compare |
v1 | 2024-01-31 | English | Compare |
Showing 1 to 6 of 6